Who founded Applikate Technologies?

Applikate Technologies was founded by Richard Torres, Michael Levene in 2018.

Who are Applikate Technologies's investors?

Applikate Technologies's investors include Creative Destruction Lab (CDL), Balderton Capital.

How much funding has Applikate Technologies raised?

Applikate Technologies has disclosed $2.6M raised across 1 round.

Where is Applikate Technologies headquartered?

Applikate Technologies is headquartered in Washington, US.

Applikate Technologies

Washington, US · Founded 2018 · Delaware corporation · 2 known investors

Find your way into Applikate Technologies

808 people in our graph share verified history with the Applikate Technologies team — schools, employers, funds. One of them is your warm intro.

Karthik Ardhanareeswaranunlockedknows Richard Torres · together at Yale University (overlapped)

×4knows the team · via Cornell

×5knows the team · via Yale University

knows the team · via Yale School of Medicine

knows the team · via University of Rochester

Applikate Technologies is a hardware and software company that has built an automated histology platform with integrated digital imaging, which stains and images whole tissue samples without physical slicing to produce histopathology data in hours. Its CHiMP platform, based on clearing histology and multiphoton microscopy, serves pathology labs and hospitals to cut processing time, lower costs, and reduce diagnostic errors.

Hardware Healthtech Medical Devices

Founders & leadership

Applikate Technologies was founded in 2018 by Richard Torres and Michael Levene.

Richard Torres inChief Executive Officer, Co-Founder2022–2026Richard Torres is a board-certified hematopathologist with training in anatomic and clinical pathology and expertise in flow cytometry, multiphoton microscopy, and digital pathology. He co-founded Applikate Technologies, which develops an automated histology platform that stains and images tissue samples to produce pathology data.

Michael Levene inCo-founder · President/COOMichael Levene holds a PhD in Computation in Neural Systems from Caltech and conducted postdoctoral research in biophysics at Cornell; he held a tenure-track faculty position in Biomedical Engineering at Yale before co-founding Applikate Technologies in 2013, where he served as co-CEO until transitioning to President and COO in 2023.

David HintNamed on SEC filing

Investors · 2

Creative Destruction Lab (CDL)Toronto · $50K – $250K

Balderton CapitalreportedLondon · $5M – $50M

Reported raises · per SEC filings

Form D private placements

$2.6M disclosed across 1 round · 2021

▶$2.6MraisedAug 2021 · 19 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Richard TorresExecutive Officer, Director
Michael LeveneExecutive Officer, Director
David HintDirector

Offering amount: $2.6M
Amount sold: $2.6M
First sale: Aug 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Applikate Technologies do?: Applikate Technologies is a hardware and software company that has built an automated histology platform with integrated digital imaging, which stains and images whole tissue samples without physical slicing to produce histopathology data in hours. Its CHiMP platform, based on clearing histology and multiphoton microscopy, serves pathology labs and hospitals to cut processing time, lower costs, and reduce diagnostic errors.
Who founded Applikate Technologies?: Applikate Technologies was founded by Richard Torres, Michael Levene in 2018.
Who are Applikate Technologies's investors?: Applikate Technologies's investors include Creative Destruction Lab (CDL), Balderton Capital.
How much funding has Applikate Technologies raised?: Applikate Technologies has disclosed $2.6M raised across 1 round.
Where is Applikate Technologies headquartered?: Applikate Technologies is headquartered in Washington, US.